The HIV 1 & 2 Antibody Quantitative CMIA test is a blood test used to detect the presence of antibodies to the human immunodeficiency virus (HIV) in a person’s blood. This test uses a Chemiluminescent Microparticle Immunoassay (CMIA) to measure the amount of antibodies present in the blood, allowing for a more accurate and quantitative measurement of the infection. HIV-1 and HIV-2 are two strains of the virus, and this test is capable of detecting both strains. However, this test cannot distinguish between acute and chronic infections, and confirmation testing is required for a definitive diagnosis. This test is commonly used for routine HIV screening and monitoring of HIV-positive individuals, as well as for monitoring the effectiveness of antiretroviral therapy. Early detection of HIV infection can lead to early treatment and improved health outcomes for individuals living with HIV.